Delivery Order SPE2DB22D2211-SPE2DB24FPCP8

Award Date 8/9/24
Potential Completion Date 8/12/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LIDOCAINE 5% PATCH 30S medical products, with a ceiling value of $1,361.04 and a period of performance through March 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a delivery order (SPE2DB20D3304|SPE2DB24FW6W6) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565334515 - LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $3,392.02 and a completion date of August 5, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4565378468 - LIDOCAINE 5% PATCH 30S, a medical product, with a ceiling value of $10,323.36. The contract has an ultimate completion date of August 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565616944 ! LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $10,010.10 and is a firm fixed price delivery order with an ultimate completion date of August 29, 2024. It is not a set-aside contract. This order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This is a $1,109.75 delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, by the Defense Logistics Agency (DLA) for the supply of 4565735143 - LIDOCAINE 5% PATCH 30S. The delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and...
The U.S. Defense Logistics Agency (DLA) awarded a $37,505.17 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, Corporate Office Division, for the supply of 4565321162 LIDOCAINE 5% PATCH 30S. This order was placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LIDOCAINE 5% PATCH 30S. The potential value of this order is $2,052.00 with a completion date of February 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,486.40 and is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 12, 2024. The contract was not set aside for any specific business type. Amerisourcebergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $3,512.13 and a completion date of May 4, 2023. The contract is a Firm Fixed Price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the contract is funded by the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $1,097.34 and a period of performance ending on July 22, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FPCP8
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $2,457.21 and a completion date of August 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities, including pharmaceutical products and medical supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/8/24, 9:26 AM